188 related articles for article (PubMed ID: 36621763)
1. Islet amyloid polypeptide does not suppress pancreatic cancer.
Taylor AJ; Panzhinskiy E; Orban PC; Lynn FC; Schaeffer DF; Johnson JD; Kopp JL; Verchere CB
Mol Metab; 2023 Feb; 68():101667. PubMed ID: 36621763
[TBL] [Abstract][Full Text] [Related]
2. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
3. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
Jeong HR; An SS
Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
[TBL] [Abstract][Full Text] [Related]
4. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo.
Mo XD; Gao LP; Wang QJ; Yin J; Jing YH
Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142
[TBL] [Abstract][Full Text] [Related]
5. Islet amyloid polypeptide exerts a novel autocrine action in β-cell signaling and proliferation.
Visa M; Alcarraz-Vizán G; Montane J; Cadavez L; Castaño C; Villanueva-Peñacarrillo ML; Servitja JM; Novials A
FASEB J; 2015 Jul; 29(7):2970-9. PubMed ID: 25808537
[TBL] [Abstract][Full Text] [Related]
6. Dissociated insulin and islet amyloid polypeptide secretion from isolated rat pancreatic islets cocultured with human pancreatic adenocarcinoma cells.
Wang F; Adrian TE; Westermark G; Gasslander T; Permert J
Pancreas; 1999 May; 18(4):403-9. PubMed ID: 10231847
[TBL] [Abstract][Full Text] [Related]
7. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
[TBL] [Abstract][Full Text] [Related]
8. Islet amyloid polypeptide in the islets of Langerhans: friend or foe?
Gebre-Medhin S; Olofsson C; Mulder H
Diabetologia; 2000 Jun; 43(6):687-95. PubMed ID: 10907112
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy.
Oosterwijk C; Höppener JW; van Hulst KL; Lips CJ
Int J Pancreatol; 1995 Aug; 18(1):7-14. PubMed ID: 7594773
[TBL] [Abstract][Full Text] [Related]
10. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
Tomita T
Islets; 2012; 4(3):223-32. PubMed ID: 22847497
[TBL] [Abstract][Full Text] [Related]
11. IAPP and type 1 diabetes: implications for immunity, metabolism and islet transplants.
Denroche HC; Verchere CB
J Mol Endocrinol; 2018 Feb; 60(2):R57-R75. PubMed ID: 29378867
[TBL] [Abstract][Full Text] [Related]
12. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Westermark P; Andersson A; Westermark GT
Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
[TBL] [Abstract][Full Text] [Related]
13. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
O'Brien TD; Butler PC; Westermark P; Johnson KH
Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
[TBL] [Abstract][Full Text] [Related]
14. Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer.
Saruc M; Iki K; Pour PM
Histol Histopathol; 2010 Apr; 25(4):423-32. PubMed ID: 20183795
[TBL] [Abstract][Full Text] [Related]
15. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer.
Chari ST; Klee GG; Miller LJ; Raimondo M; DiMagno EP
Gastroenterology; 2001 Sep; 121(3):640-5. PubMed ID: 11522748
[TBL] [Abstract][Full Text] [Related]
16. IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes.
Blencowe M; Furterer A; Wang Q; Gao F; Rosenberger M; Pei L; Nomoto H; Mawla AM; Huising MO; Coppola G; Yang X; Butler PC; Gurlo T
Diabetologia; 2022 Jan; 65(1):173-187. PubMed ID: 34554282
[TBL] [Abstract][Full Text] [Related]
17. Islet amyloid polypeptide/amylin messenger RNA and protein expression in human insulinomas in relation to amyloid formation.
van Hulst KL; Oosterwijk C; Born W; Vroom TM; Nieuwenhuis MG; Blankenstein MA; Lips CJ; Fischer JA; Höppener JW
Eur J Endocrinol; 1999 Jan; 140(1):69-78. PubMed ID: 10037255
[TBL] [Abstract][Full Text] [Related]
18. Two novel immortal pancreatic beta-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid.
Andrikopoulos S; Verchere CB; Teague JC; Howell WM; Fujimoto WY; Wight TN; Kahn SE
Diabetes; 1999 Oct; 48(10):1962-70. PubMed ID: 10512360
[TBL] [Abstract][Full Text] [Related]
19. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes.
Matveyenko AV; Butler PC
ILAR J; 2006; 47(3):225-33. PubMed ID: 16804197
[TBL] [Abstract][Full Text] [Related]
20. Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes?
Johnson KH; O'Brien TD; Westermark P
Diabetes; 1991 Mar; 40(3):310-4. PubMed ID: 1999270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
